🇺🇸 FDA

Intelligence · Drug directory

Pipeline & Investigational Drugs

Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.

Quick answer

Pipeline & investigational drugs: NovaPharmaNews tracks 1,610 pharmaceutical drugs in this segment. Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.

1,610 drugs · Pipeline · by data quality · Page 6 of 68

  1. masitinib

    MASITINIB AB SCIENCE

    EMA: refused

    L01EX06

  2. matrix-applied characterised autologous cultured chondrocytes

    MACI

    EMA: unknown

    M09AX02

  3. mecasermin rinfabate

    IPLEX

    EMA: application withdrawn

  4. meningococcal groups a, c, w, y conjugate and group b vaccine (recombinant, adsorbed)

    PENBRAYA

    EMA: withdrawn

    J07AH11

  5. milnacipran

    IMPULSOR

    EMA: refused

  6. molnupiravir

    LAGEVRIO Merck KGaA, Darmstadt, Germany

    EMA: application withdrawn · TGA: approved · PMDA: approved

    J05A

  7. moxetumomab pasudotox

    LUMOXITI

    EMA: withdrawn

    L01X

  8. nadofaragene firadenovec

    ADSTILADRIN

    EMA: unknown

    L01XL10

  9. naproxcinod

    BEPRANA

    EMA: application withdrawn

  10. nelfinavir

    VIRACEPT

    EMA: withdrawn

    J05AE04

  11. nimotuzumab

    THERALOC

    EMA: application withdrawn · NMPA: clinical trials

  12. nomegestrol acetate

    IOA

    EMA: withdrawn

    G03AA14

  13. oblimersen

    GENASENSE

    EMA: refused

  14. omecamtiv mecarbil

    KINHARTO

    EMA: application withdrawn

    C01CX10

  15. oportuzumab monatox

    OPORTUZUMAB MONATOX DLRC PHARMA SERVICES

    EMA: application withdrawn

    L01FX06

  16. pancreas powder

    ENZEPI

    EMA: withdrawn

    A09AA02

  17. pandemic influenza vaccine (h1n1) (split virion, inactivated, adjuvanted)

    HUMENZA

    EMA: withdrawn

    J07BB02

  18. pandemic influenza vaccine (h1n1)v (split virion, inactivated, adjuvanted)

    AREPANRIX

    EMA: withdrawn

    J07BB02

  19. pandemic influenza vaccine (h5n1) (whole virion, inactivated, prepared in cell culture)

    PANDEMIC INFLUENZA VACCINE H5N1 BAXTER AG

    EMA: withdrawn

    J07BB01

  20. pandemic influenza vaccine (whole virion, inactivated, adjuvanted)

    DARONRIX

    EMA: unknown

    J07BB01

  21. para-aminosalicylic acid

    GRANUPAS (PREVIOUSLY PARA-AMINOSALICYLIC ACID LUCANE)

    EMA: withdrawn

    J04AA01

  22. parathyroid hormone (rdna)

    PREOTACT

    EMA: withdrawn

    H05AA03

  23. parsaclisib

    PARSACLISIB INCYTE BIOSCIENCES DISTRIBUTION B.V.

    EMA: application withdrawn

    L01EM04

  24. pegaptanib

    MACUGEN

    EMA: withdrawn

    S01LA03

Frequently asked questions

How many pipeline drugs are listed?

1,610 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.